View PDF version of press release

Contact:
Jennifer Tilliss, Linhart PR
303-951-2566
jtilliss@linhartpr.com

FOR IMMEDIATE RELEASE

Ganeden Biotech and Pathway International Announce Exclusive Distribution Partnership
Pathway International to serve as exclusive Australian and New Zealand distributor for GanedenBC30 probiotic

CLEVELAND (Feb. 3, 2010) Ganeden Biotech Inc., makers of the patented probiotic strain GanedenBC30®, today announced a partnership with Pathway International Pty Ltd to exclusively distribute GanedenBC30 in all Australian and New Zealand markets.

The partnership will provide growth opportunities for Ganeden Biotech through increased distribution channels and access to an exclusive international supply chain network of leading manufacturers in Australia and New Zealand.

“Partnering with Pathway International is an important step in achieving our global expansion goals for 2010,” said Andrew Lefkowitz, Ganeden iotech president and CEO. “We are confident that Pathway International’s proven track record in successfully distributing innovative health and wellness ingredients will help our probiotic reach consumers in these markets looking to improve their digestive health and boost immunity with probiotic-enhanced food, beverage and supplement products.”

Since 2008, GanedenBC30 has been incorporated in more than 40 products widely distributed throughout North America. Due to the unique ability of the shelf-stable probiotic to survive harsh manufacturing processes, it can be incorporated into a variety of products ranging from frozen yogurt to baked goods.

“We look forward to a long-term relationship with Ganeden Biotech through which we can help introduce GanedenBC30 to new markets and manufacturers interested in innovative functional ingredients,” said Wayne Coote, managing director of Pathway International.

About Ganeden Biotech

Founded in 1996, Ganeden Biotech Inc. is a private company based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage and Sustenex brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications as well as in medical foods and dietary supplements. GanedenBC30 was found to be Generally Recognized As Safe (GRAS) by an independent expert panel assembled to assess its safety in use as a food ingredient. Digestive Advantage and Sustenex are available at over 40,000 retailers nationwide including Wal–Mart, CVS/pharmacy, Walgreens, Rite–Aid, Stop & Shop, Giant, Publix, Kroger, and Target. For more information, visit www.digestiveadvantage.com, www.sustenex.com, or www.ganedenlabs.com.

About Pathway International Pty Ltd.

Pathway is the exclusive distributor in Australia and New Zealand for leading suppliers of high quality and innovative ingredients that add value to the health care and nutrition industries.  For more information visit www.pathway.net.au

# # #